RNAを用いた治療法は、慢性疾患の治療に優れた可能性を持つことから、近年、多くの関心を集めています。さらに、RNAワクチンは、製造、普及、安全性の面で、DNAワクチンよりも多くの利点があります。mRNAワクチンや治療法は、ヒトの臨床試験で有望視されており、そのニーズは高まっています。また、ModernaとPfizer-BioNTechが開発したCOVID-19ワクチンの人気により、腫瘍学の臨床試験でテストされるmRNAベースのワクチン治療の数が急増しています。さらに、2021年には、癌患者を対象としたmRNAワクチンの臨床試験数がCOVID-19試験に次いで多く、業界の拡大に拍車をかけました。この市場拡大の背景には、プロピオン酸血症、メチルマロン酸血症、グリコーゲン病、フェニルケトン尿症、代謝・免疫疾患などの希少疾患や、癌、心臓病、肺疾患、CKDなどの慢性疾患の発生率が増加していることがあります。例えば、Globocanによると、2020年12月の世界のがん関連死亡者数は1060万人、癌の新規患者数は1930万人となっています。さらに、mRNAワクチンの人気、テーラーメイドの癌治療薬の開発、新製品の強力なパイプラインによりmRNAワクチンおよび治療薬の需要が高まり、予測期間中の業界成長に拍車がかかります。しかし、熟練した専門家の不足が、今後一定期間の市場成長の妨げになると予想されます。
mRNA療法の世界市場調査において考慮した主要地域には、アジア太平洋地域、北アメリカ、ヨーロッパ、ラテンアメリカ、その他の世界の地域が含まれます。北アメリカは市場を独占しており、予測期間中、最も速い速度で成長すると思われます。北アメリカの市場は、大規模な研究資金の利用可能性、RNAベースの治療に対する連邦政府のプログラムの拡大、臨床研究数の増加によって牽引されるでしょう。例えば、Grahamらの基礎研究は、2020年11月に国立衛生研究所（NIH）、国防総省、連邦政府が出資する学術研究所から支援を受けました。この支援は、COVID-19に対するワクチンを迅速に発見するための重要な要因となっています。政府は、納品を早めるために、パンデミック開始以来、ワクチン製造業者に105億米ドルを追加で支給しています。
この調査の目的は、近年の様々なセグメントおよび国々の市場規模を定義し、今後8年間の価値を予測することです。本レポートは、調査対象となる各地域・国における産業の質的・量的側面を取り込むように設計されています。さらに、市場の今後の成長を決定づける推進要因や課題などの重要な側面に関する詳細情報も提供しています。さらに、主要企業の競合状況や製品提供の詳細な分析とともに、利害関係者が投資できるミクロ市場での機会についても報告します。
目次
Table of Contents
Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2028 (USD Billion)
1.2.1. mRNA therapeutics Market, by region, 2020-2028 (USD Billion)
1.2.2. mRNA therapeutics Market, by Application, 2020-2028 (USD Billion)
1.2.3. mRNA therapeutics Market, by Type, 2020-2028 (USD Billion)
1.2.4. mRNA therapeutics Market, by End-User, 2020-2028 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global mRNA therapeutics Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global mRNA therapeutics Market Dynamics
3.1. MRNA therapeutics Market Impact Analysis (2020-2028)
3.1.1. Market Drivers
3.1.1.1. Increasing prevalence of chronic diseases
3.1.1.2. Surging geriatric population
3.1.2. Market Challenges
3.1.2.1. Lack of skilled professionals
3.1.3. Market Opportunities
3.1.3.1. Increasing R&D spending in mRNA therapeutics s
Chapter 4. Global mRNA therapeutics Market Industry Analysis
4.1. Porter's 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter's 5 Force Model (2018-2028)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
4.5. Top investment opportunity
4.6. Top winning strategies
Chapter 5. Risk Assessment: COVID-19 Impact
5.1.1. Assessment of the overall impact of COVID-19 on the industry
5.1.2. Pre COVID-19 and post COVID-19 market scenario
Chapter 6. Global mRNA therapeutics Market, by Application
6.1. Market Snapshot
6.2. Global mRNA therapeutics Market by Application, Performance - Potential Analysis
6.3. Global mRNA therapeutics Market Estimates & Forecasts by Application, 2018-2028 (USD Billion)
6.4. mRNA therapeutics Market, Sub Segment Analysis
6.4.1. Rare genetic diseases
6.4.2. Oncology
6.4.3. Respiratory diseases
6.4.4. Infectious disease
6.4.5. Others
Chapter 7. Global mRNA therapeutics Market, by Type
7.1. Market Snapshot
7.2. Global mRNA therapeutics Market by Type, Performance - Potential Analysis
7.3. Global mRNA therapeutics Market Estimates & Forecasts by Type, 2018-2028 (USD Billion)
7.4. MRNA therapeutics Market, Sub Segment Analysis
7.4.1. Prophylactic Vaccines
7.4.2. Therapeutic Vaccines
7.4.3. Therapeutic Drugs
Chapter 8. Global mRNA therapeutics Market, by End-User
8.1. Market Snapshot
8.2. Global mRNA therapeutics Market by End-User, Performance - Potential Analysis
8.3. Global mRNA therapeutics Market Estimates & Forecasts by End-User, 2018-2028 (USD Billion)
8.4. MRNA therapeutics Market, Sub Segment Analysis
8.4.1. Hospitals & Clinics
8.4.2. Research Organizations
8.4.3. Others
Chapter 9. Global mRNA therapeutics Market, Regional Analysis
9.1. mRNA therapeutics Market, Regional Market Snapshot
9.2. North America mRNA therapeutics Market
9.2.1. U.S. mRNA therapeutics Market
9.2.1.1. Application breakdown estimates & forecasts, 2018-2028
9.2.1.2. Type breakdown estimates & forecasts, 2018-2028
9.2.1.3. End-User breakdown estimates & forecasts, 2018-202
9.2.2. Canada mRNA therapeutics Market
9.3. Europe mRNA therapeutics Market Snapshot
9.3.1. U.K. mRNA therapeutics Market
9.3.2. Germany mRNA therapeutics Market
9.3.3. France mRNA therapeutics Market
9.3.4. Spain mRNA therapeutics Market
9.3.5. Italy mRNA therapeutics Market
9.3.6. Rest of Europe mRNA therapeutics Market
9.4. Asia-Pacific mRNA therapeutics Market Snapshot
9.4.1. China mRNA therapeutics Market
9.4.2. India mRNA therapeutics Market
9.4.3. Japan mRNA therapeutics Market
9.4.4. Australia mRNA therapeutics Market
9.4.5. South Korea mRNA therapeutics Market
9.4.6. Rest of Asia Pacific mRNA therapeutics Market
9.5. Latin America mRNA therapeutics Market Snapshot
9.5.1. Brazil mRNA therapeutics Market
9.5.2. Mexico mRNA therapeutics Market
9.6. Rest of The World mRNA therapeutics Market
Chapter 10. Competitive Intelligence
10.1. Top Market Strategies
10.2. Company Profiles
10.2.1. Moderna, Inc.
10.2.1.1. Key Information
10.2.1.2. Overview
10.2.1.3. Financial (Subject to Data Availability)
10.2.1.4. Application Summary
10.2.1.5. Recent Developments
10.2.2. Biontech Se
10.2.3. Centogene Ag
10.2.4. Arcturus Therapeutics
10.2.5. Translate Bio, Inc.
10.2.6. GSK Plc.
10.2.7. Argos Therapeutics Inc.
10.2.8. Sangamo Therapeutics, Inc.
10.2.9. Avrobio, Inc.
10.2.10. Pfizer Inc
Chapter 11. Research Process
11.1. Research Process
11.1.1. Data Mining
11.1.2. Analysis
11.1.3. Market Estimation
11.1.4. Validation
11.1.5. Publishing
11.2. Research Attributes
11.3. Research Assumption
LIST OF TABLES
TABLE 1. Global mRNA therapeutics Market, report scope
TABLE 2. Global mRNA therapeutics Market estimates & forecasts by Region 2018-2028 (USD Billion)
TABLE 3. Global mRNA therapeutics Market estimates & forecasts by Application 2018-2028 (USD Billion)
TABLE 4. Global mRNA therapeutics Market estimates & forecasts by Type 2018-2028 (USD Billion)
TABLE 5. Global mRNA therapeutics Market estimates & forecasts by End-User 2018-2028 (USD Billion)
TABLE 6.
TABLE 7. Global mRNA therapeutics Market by segment, estimates & forecasts, 2018-2028 (USD Billion)
TABLE 8. Global mRNA therapeutics Market by region, estimates & forecasts, 2018-2028 (USD Billion)
TABLE 9. Global mRNA therapeutics Market by segment, estimates & forecasts, 2018-2028 (USD Billion)
TABLE 10. Global mRNA therapeutics Market by region, estimates & forecasts, 2018-2028 (USD Billion)
TABLE 11. Global mRNA therapeutics Market by segment, estimates & forecasts, 2018-2028 (USD Billion)
TABLE 12. Global mRNA therapeutics Market by region, estimates & forecasts, 2018-2028 (USD Billion)
TABLE 13. Global mRNA therapeutics Market by segment, estimates & forecasts, 2018-2028 (USD Billion)
TABLE 14. Global mRNA therapeutics Market by region, estimates & forecasts, 2018-2028 (USD Billion)
TABLE 15. Global mRNA therapeutics Market by segment, estimates & forecasts, 2018-2028 (USD Billion)
TABLE 16. Global mRNA therapeutics Market by region, estimates & forecasts, 2018-2028 (USD Billion)
TABLE 17. U.S. mRNA therapeutics Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 18. U.S. mRNA therapeutics Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 19. U.S. mRNA therapeutics Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 20. Canada mRNA therapeutics Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 21. Canada mRNA therapeutics Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 22. Canada mRNA therapeutics Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 23. UK mRNA therapeutics Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 24. UK mRNA therapeutics Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 25. UK mRNA therapeutics Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 26. Germany mRNA therapeutics Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 27. Germany mRNA therapeutics Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 28. Germany mRNA therapeutics Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 29. RoE mRNA therapeutics Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 30. RoE mRNA therapeutics Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 31. RoE mRNA therapeutics Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 32. China mRNA therapeutics Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 33. China mRNA therapeutics Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 34. China mRNA therapeutics Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 35. India mRNA therapeutics Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 36. India mRNA therapeutics Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 37. India mRNA therapeutics Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 38. Japan mRNA therapeutics Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 39. Japan mRNA therapeutics Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 40. Japan mRNA therapeutics Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 41. RoAPAC mRNA therapeutics Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 42. RoAPAC mRNA therapeutics Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 43. RoAPAC mRNA therapeutics Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 44. Brazil mRNA therapeutics Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 45. Brazil mRNA therapeutics Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 46. Brazil mRNA therapeutics Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 47. Mexico mRNA therapeutics Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 48. Mexico mRNA therapeutics Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 49. Mexico mRNA therapeutics Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 50. RoLA mRNA therapeutics Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 51. RoLA mRNA therapeutics Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 52. RoLA mRNA therapeutics Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 53. Row mRNA therapeutics Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 54. Row mRNA therapeutics Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 55. Row mRNA therapeutics Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 56. List of secondary sources, used in the study of global mRNA therapeutics Market
TABLE 57. List of primary sources, used in the study of global mRNA therapeutics Market
TABLE 58. Years considered for the study
TABLE 59. Exchange rates considered
LIST OF FIGURES
FIG 1. Global mRNA therapeutics Market, research methodology
FIG 2. Global mRNA therapeutics Market, market estimation techniques
FIG 3. Global market size estimates & forecast methods
FIG 4. Global mRNA therapeutics Market, key trends 2021
FIG 5. Global mRNA therapeutics Market, growth prospects 2022-2028
FIG 6. Global mRNA therapeutics Market, porters 5 force model
FIG 7. Global mRNA therapeutics Market, pest analysis
FIG 8. Global mRNA therapeutics Market, value chain analysis
FIG 9. Global mRNA therapeutics Market by segment, 2018 & 2028 (USD Billion)
FIG 10. Global mRNA therapeutics Market by segment, 2018 & 2028 (USD Billion)
FIG 11. Global mRNA therapeutics Market by segment, 2018 & 2028 (USD Billion)
FIG 12. Global mRNA therapeutics Market by segment, 2018 & 2028 (USD Billion)
FIG 13. Global mRNA therapeutics Market by segment, 2018 & 2028 (USD Billion)
FIG 14. Global mRNA therapeutics Market, regional snapshot 2018 & 2028
FIG 15. North America mRNA therapeutics Market 2018 & 2028 (USD Billion)
FIG 16. Europe mRNA therapeutics Market 2018 & 2028 (USD Billion)
FIG 17. Asia Pacific mRNA therapeutics Market 2018 & 2028 (USD Billion)
FIG 18. Latin America mRNA therapeutics Market 2018 & 2028 (USD Billion)
FIG 19. Global mRNA therapeutics Market, company market share analysis (2021)
